Alankit (ALANKIT)

Turnaround

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹8.29
Market Cap₹224.79 Cr
P/E Ratio11.84
ROCE11.29%
ROE3.82%
Dividend Yield0%
Profit Growth-34.62%
Debt/Equity0.06
Sales Growth-15.27%
Promoter Holding54.15%
52-Week Range₹6.8 — ₹14.16
SectorCommercial Services & Supplies
Book Value₹11.86

Strengths

Concerns

AI Analysis

At ₹9.15, Alankit offers a classic Graham setup — a share trading below its book value of ₹11.46, with a price-to-book of 0.80. That gives me a margin of safety on the balance sheet, but a margin of safety doesn't make a good investment by itself. The business must earn a decent return on that book value. Here I am disappointed: ROE is only 3.82%. For every ₹100 of equity, the company earns less than ₹4. ROCE of 11.29% is more acceptable, but it is not a moat. A truly wonderful company would have dominant pricing power and high, stable returns; Alankit is in diversified commercial services, a field where competition is intense and pricing power is limited. The balance sheet is conservative — debt-to-equity of 0.07 — so the company is not going to sink under leverage. Profit growth of 46.95% looks exciting, but I must ask why sales fell 1.47% at the same time. Rising profit on falling sales often comes from cost cuts, not underlying strength. The latest quarter net profit of ₹8 Cr on revenue of ₹72 Cr is a sharp margin, but I would want to see if that margin is sustainable. The market is not paying much: P/E of 9.84 and PEG of 0.21 imply the Street expects continued growth. However, with a 0% dividend yield, the retail investor is asked to wait patiently for capital gains with no cash compensation. Promoter holding of 54.15% is good; interests are aligned. The Piotroski score of 6/9 is decent, not excellent. This is more a turnaround candidate than a durable compounder. If earnings quality persists and revenue turns positive, the stock is cheap; if not, the discount to book may widen.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer